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ARTICLE
Combining Evidence of Natural Selection with Association
Analysis Increases Power to Detect Malaria-Resistance Variants
George Ayodo, Alkes L. Price, Alon Keinan, Arthur Ajwang, Michael F. Otieno, Alloys S. S. Orago,
Nick Patterson, and David Reich
Statistical power to detect disease variants can be increased by weighting candidates by their evidence of natural selection.
To demonstrate that this theoretical idea works in practice, we performed an association study of 10 putative resistance
variants in 471 severe malaria cases and 474 controls from the Luo in Kenya. We replicated associations at HBB (Pp
) and CD36 ( ) but also showed that the same variants are unusually differentiated in frequency between.0008 Pp .03
the Luo and Yoruba (who historically have been exposed to malaria) and the Masai and Kikuyu (who have not been
exposed). This empirically demonstrates that combining association analysis with evidence of natural selection can
increase power to detect risk variants by orders of magnitude—up to for HBB and for CD36.Pp .000018 Pp .00043
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Malaria infection (MIM 248310) has exerted severe pres-
sure on the human genome within the past 10,000 years,1–
3 and there are more cases today than ever before, with
an estimated 300–660 million new episodes of clinical
Plasmodium falciparum malaria every year.4 Despite high
infection rates, only 1%–2% of patients develop life-
threatening complications, such as cerebral malaria and
profound anemia,5 so natural selectionhas likely operated,
to a large extent, on severity. In the context of high in-
fection rates, the genetics of host response are likely to
play an important role.6 In sub-Saharan Africa, the pop-
ulations in which malaria is endemic generally have a
lower proportion of cases with severe disease.5,7 This sug-
gests that there exist genetic variants that have risen to
higher frequency inmalaria-endemic populations because
they modulate risk of P. falciparum malaria, similar to the
case of the Duffy-null variant that protects against P. vivax
malaria.8
A handful of genetic variants have already been asso-
ciated with risk of or protection against severe malaria
infection.5 Our ﬁrst objective in this study was to test var-
iants of b-globin (HbAS9,10), intercellular adhesion mole-
cule (ICAM TT11), CD36 (CD36GT12), nitric oxide synthase
(NOS2A 1659 AA13), tumor necrosis factor (TNF 238 A14
and TNF 308 A14–16), Fc g-receptor IIA (CD32 AA17,18), in-
terferon-a receptor-1 (IFNARI LI168V CC19 and IFNARI
17470 CC19), and Toll-like receptor (TLR420), which had
previously been associated withmalaria susceptibility. The
particular phenotype we focused on was high levels of
parasitemia in young children due to malaria infection.
Second, we compared the frequency differentiation in
populations in which malaria is endemic and in closely
related populations in which it is not endemic, searching
for the differences that would be expected if natural se-
lection had affected those alleles in one population but
not in the other, because malaria began to affect only one
group. Finally, we formally combined the evidence of as-
sociation from case-control studies with evidence of nat-
ural selection in populations that have been exposed to
malaria infection. We note that there has been discussion
elsewhere of how one could formally combine case-con-
trol association studies with statistical weights obtained
on the basis of evidence of natural selection.21 Our goal
in this study was to empirically demonstrate the power
of this approach.
Material and Methods
Human Subjects
We collected 471 severe malaria cases and 474 controls from the
Luo ethnic group, a population that speaks a Nilotic language
and lives in a malaria-endemic region in western Kenya. All the
severe malaria cases were collected from the Bondo District Hos-
pital’s children’s emergency ward or from its outpatient clinic
between May 2004 and August 2005. The average age of the cases
was 2.6 years (table 1), reﬂecting our focus on individuals with
no previous immunological protection against malaria. The con-
trols were randomly collected from volunteers at nearby second-
ary schools, with an average age of 16.9 years (table 1).We focused
on older controls, because we knew that they had survived to an
older age. Thus, the control samples selected for this study may
be slightly enriched for variants protecting against severemalaria,
which should make it slightly easier to detect associations.
For the selection study, we assembled population control sam-
ples from the Masai, Kikuyu, and Yoruba ethnic groups. We col-
lected samples from the Masai and Kikuyu from secondary
schools in Narok and Nyeri, Kenya, respectively (table 1). The
Yoruba samples were from the International Haplotype Map pro-
ject22; we analyzed data from unrelated men and women, the
parents in HapMap mother-father-child trios.
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Table 1. Characteristics of the Populations Included in This Study
Population
Mean
Age (Range)
No. in Sample
(Male/Female) Source
Malaria
Endemicity
Altitude above
Sea Level
(m)
Luo cases 2.6 (1.5–10.0) 471 (232/239) Bondo District Hospital, Kenya Endemic ∼1,240
Luo controls 16.9 (14–20) 474 (290/184) Bondo schools, Kenya Endemic ∼1,240
Masai controls 16.9 (13–21) 97 (42/55) Narok schools, Kenya Nonendemic ∼1,880
Kikuyu controls 17.1 (15–19) 110 (46/64) Nyeri schools, Kenya Nonendemic ∼1,950
Yoruba controls NAa 55 (27/28) International Haplotype Map Endemic ∼700
a NA p not available.
About 2 ml of blood was obtained by venipuncture for all the
samples we collected in Kenya. We extracted DNA within 10 h
of blood collection, using a Qiagen DNA Bloodmini kit, and then
stored it at 20C. All the participants provided informed con-
sent, and, for children, informed consent was obtained from the
parents and/or guardians. The study was reviewed and approved
by the Harvard Medical School and Kenyatta University ethical
review boards and by the Kenyan government.
Clinical Identiﬁcation of Human Subjects with Severe
Malaria
We identiﬁed human subjects who had severe malaria according
to World Health Organization criteria. Blood smears and Giemsa
staining were used to determine the asexual parasite count (par-
asitemia level). We identiﬁed cases as young children with 112
parasites per 200 red blood cells. All cases were also required to
have overlapping clinical manifestations at the time of hospital-
ization, such as respiratory distress, convulsions, prostration, and
hyperthermia (139C).
Genotyping at Candidate Genetic Variants
We genotyped all human subjects for 13 candidate malaria SNPs,
using mass spectrometry (Sequenom).23 We discarded SNPs with
minor-allele frequency averaging !5% across the four ethnic
groups, leaving 10 SNPs for subsequent analysis (table 2). Al-
though the X-linked G6PD and CD40 genes are important can-
didates for malaria-resistance genes,3 we excluded them from this
study because we wished to focus on autosomal SNPs that we
could compare with an empirical panel of autosomal variants in
the genome.
As an assessment of genotyping quality, we observed that, for
85 genotypes obtained in duplicate, there were 2 discrepancies,
for a discordance rate of 2.4%. After removing samples with !80%
genotyping completeness, we found that the average complete-
ness of genotypes was 97.8%. We also compared genotyping of
10 SNPs in Yoruba samples with data from HapMap.22 Of 30 ge-
notypes obtained in duplicate, there was 1 discrepancy (3.33%).
All SNPs were in Hardy-Weinberg equilibrium in all the ethnic
groups we studied ( ).P 1 .05
Genotyping at 1,454 Random SNPs
For the assessment of allele-frequency differentiation at random
SNPs, we used the Illumina Bead Lab System to genotype 1,536
random SNPs from the Illumina linkage panel (covering chro-
mosomes 1, 2, 3, and 22) in 45 of the Luo controls, 47 Masai
controls, and 37 Kikuyu controls. We also obtained genotypes for
these SNPs in 55 Yoruba samples from the HapMap database.22
Of these SNPs, 1,454 passed standard quality checks and had been
genotyped in all four populations.
Case-Control Association Analysis
We assessed the statistical signiﬁcance of allele-frequency differ-
ences between Luo cases and Luo controls, using a x2 test with
1 df. We used a one-tailed test of statistical signiﬁcance, since our
interest was in assessing whether a genotype or allele previously
associated withmalaria ismore common in cases than in controls.
We computed odds ratios (ORs) as Ap (f /1 f )/(f /1case case control
, where fcase is the frequency in cases and fcontrol is the fre-f )control
quency in controls. We also computed a 95% CI as the range of
ORs that produced a likelihood ratio consistent with the data
( ). Speciﬁcally, we estimated the SE of the log OR asP 1 .05
0.5
1 1 1 1
Bp    ,( )n n n ncase-ref case-var control-ref control-var
where ncase-ref and ncase-var are the counts of the reference and vari-
ant genotypes in cases, and ncontrol-ref and ncontrol-var are the anala-
gous quantities in controls. The 95% CI is quoted as the range
( to ).ln(A)1.65B ln(A)1.65Be e
Epistasis Testing
To test for possible epistasis between any two SNPs, we used lo-
gistic regression. We compared the ﬁt of three models with the
data (case-control status for all the Luo samples): (1) genotype at
the ﬁrst SNP, (2) genotype at the second SNP, and (3) genotype
at both SNPs.24 We performed a one-tailed test for association
with the genotypes previously associated with malaria. We cal-
culated a Wald statistic and assessed signiﬁcance for the epistatic
interaction by a x2 test with 1 df.
Statistical Test for Natural Selection
The model of allele-frequency differentiation between two pop-
ulations that we used to test for selection is that the difference
in population frequencies at a given polymorphism is normally
distributed with mean 0 and variance cp(1p), where p is the
ancestral frequency. This model is similar to that of Nicholson et
al.,25 who showed that, for populations with modest genetic di-
vergence times, it is a good approximation for allele-frequency
differentiation. Under certain assumptions, the c parameter is
expected to equal 2#FST. From a population genetics perspective,
c can be viewed as measuring genetic drift between populations.
To estimate c empirically, we used data from the 1,454 ran-
domly chosen markers. For a given pair of populations, we es-
timated c as the empirical variance of the difference in population
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Table 2. Replication Analysis for 10 Genotypes or Alleles Previously Associated with Malaria Susceptibility
Genotype or Allele Reference SNP
Direction of
Previous
Association
Frequency in
Controls
(%)
No. of Cases/Controls
Genotyped OR (95% CI) P
HbAS10 rs334 Protectiona,b 25 447/454 .57 (.41–.79) .0004
CD36 GT12 rs3211938 Riskc 12 456/457 1.50 (1.03–2.18) .015
ICAM TT11 rs5491 Protectiona 7 460/455 .71 (.42–1.21) .10
NOS2A 1659 AA13 rs8078340 Riskc,d 6 450/455 .42 (.21–.83) .99
TNF 238 A14,15 rs361525 Riskc 9 459/457 1.00 (.73–1.39) .49
CD32 AA17,18 rs1801274 Protectiond,e 25 455/447 .95 (.71–1.29) .38
IFNARI LI168V CC19 rs2257167 Protectionc 3 455/457 1.18 (.54–2.07) .76
TNF 308 A14,16 rs1800629 Riskc 9 450/433 1.13 (.82–1.56) .21
IFNARI 17470 CC19 rs1012335 Protectionc 3 455/452 .85 (.53–1.36) .34
TLR4 AG20 rs4986790 Riska 10 407/303 1.36 (.85–2.17) .10
a Previously published association with severe malaria.
b Previously published association with mild malaria.
c Previously published association with cerebral malaria.
d Previously published association with severe malarial anemia.
e Previously published association with parasitemia.
frequencies, after normalizing by p(1p) and accounting for sam-
pling noise, which has variance , where N1p(1 p)(1/N  1/N )1 2
and N2 are total allele counts for the two populations at a given
marker. We approximated the normalization term p(1p) by set-
ting p equal to the average of observed frequencies of the two
populations, and we approximated binomial sampling noise as
normally distributed. The same approximations were applied
both to our estimation of c and to our subsequent analysis of
individual markers. SNPs with average minor-allele frequency
!5% for the two populations being compared were omitted from
all computations, since the normal approximation becomes less
reliable (table 3).
To test whether an individual marker was more differentiated
than expected between two populations, we compared the ob-
served difference in frequency with the expected distribution
, using the value of c estimatedN[0,p(1 p)(c 1/N  1/N )]1 2
above, and computed a x2 statistic with 1 df. A feature of this test
is that the x2 statistic has a mean value of 1 across the set of
markers used to infer c. The test appropriately handles different
sample sizes for candidate markers versus random markers used
to infer c. A detailed statistical treatment will appear elsewhere
(A.L.P, N.P., and D.R., unpublished data).
Combining Case-Control Association and the Test
for Differentiating Selection
The combined test formally evaluates whether the observed data
are consistent with the model of no case-control association and
no selection. The test is performed by summing the association
x2 statistic and the differentiation x2 statistic, forming a x2 statistic
with 2 df. We note that the association x2 statistic used in this
test is, by deﬁnition, a two-tailed statistic. We computed this sum
for each pair of populations, using the same association statistic
in each case. When one of the two populations being compared
was the Luo population, we used the summed counts of Luo cases
and Luo controls in the combined statistics reported in table 4.
This generally leads to less signiﬁcant P values than does using
Luo controls only (and so is conservative). Using summed counts
of Luo cases and Luo controls is appropriate under the null as-
sumption of no association and ensures that the association sta-
tistic and differentiation statistic are independent. However, for
the selection-only statistics reported in table 3, we used Luo con-
trols only, since we wished to evaluate the evidence of selection
in the control population, without regard to evidence of case-
control association.
Results
Case-Control Association
We tested each of the 10 variants for association with
malaria, comparing Luo cases with Luo controls. Two of
the variants showed nominally statistically signiﬁcant as-
sociations by one-tailed tests that searched for an associ-
ation with the genotype or allele previously proposed to
affect malaria resistance (table 3). We replicated the well-
known association in which heterozygotes for the sickle-
cell trait HbAS (HbAS T) are protected against severe ma-
laria ( ; OR 0.57 [95% CI 0.41–0.79]) (see thePp .0004
“Material andMethods” section). Although the OR of 0.57
is less strong than that observed in some previous studies,9
it is in the same range as the OR of 0.45 (0.24–0.84), which
was observed in another study of young children with a
similar phenotype of severe malaria.10 Different case-con-
trol studies focus on different phenotypes, and the pro-
tection of HbAS against severe malaria is known to vary
with age,26 so it is not surprising that the estimated ORs
are heterogeneous across studies. We also replicated the
association in which heterozygotes for CD36 GT are at
increased risk for severe malaria ( ; OR 1.50 [95%P ! .015
CI 1.03–2.18]).12
We note in passing that NOSA (rs8078340) gives a nom-
inally signiﬁcant P value (by a two-tailed test), but the
association is in the opposite direction to previous reports
( ) (table 2). Our null ﬁndings at the other variantsPp .99
do not necessarily mean that they are unassociated; the
CIs for the ORs are broad (table 2) and are often consistent
with substantial association. We also note that our study
included only individuals with parasitemia; we had no
power to detect associations that were speciﬁc to cerebral
malaria, a phenotype that was the focus of some previous
studies.13,27,28
www.ajhg.org The American Journal of Human Genetics Volume 81 August 2007 237
Table 3. Tests for Differentiating Selection between Malaria-Endemic and -Nonendemic Populations
Allele
Reference
SNP
Allele Frequency (%) (No. of Alleles Used
in Assessment) Pa
Luo Yoruba Masai Kikuyu
Luo vs.
Masai
Luo vs.
Kikuyu
Yoruba vs.
Masai
Yoruba vs.
Kikuyu
HbAS T rs334 13 (908) 11 (102) 0 (194) 0 (200) .00149 .00036 .044 .025
CD36 G rs3211938 6 (914) 22 (100) 1 (186) 0 (202) NA NA .00590 .00096
ICAM T rs5491 25 (910) 24 (100) 16 (186) 18 (206) .19 .25 .41 .48
NOS2A 1659 A rs8078340 21 (910) 19 (98) 25 (188) 21 (204) .62 .86 .57 .89
TNF 238 A rs361525 9 (914) 1 (100) 21 (192) 16 (202) .04 .13 .00741 .010
CD32 A rs1801274 50 (900) 50 (98) 50 (190) 44 (210) 1.0 .37 1.0 .56
IFNARI L168V C rs2257167 16 (914) 16 (98) 25 (192) 19 (208) .20 .61 .37 .72
TNF 308 A rs1800629 9 (866) 6 (96) 6 (188) 7 (204) .60 .74 1.0 .84
IFNARI 17470 C rs1012335 32 (904) 22 (108) 33 (190) 35 (202) .92 .64 .32 .18
TLR4 G rs4986790 5 (633) 4 (114) 7 (178) 5 (170) .60 1.0 .6 .84
a P values for selection are based on allele-frequency differentiation tests between malaria-endemic (Luo and Yoruba) and -nonendemic populations
(Kikuyu and Masai). Values in bold are signiﬁcant. Statistics for SNPs with average minor-allele frequency !5% for the two populations analyzed
are denoted as NA (not available).
Finally, we tested for epistatic interactions between each
pair of variants,29 but no pair showed a statistically sig-
niﬁcant interaction by a Wald test (not shown). We also
tested for different strengths of association by sex but
found no evidence of this (table A1).
Allele-Frequency Differentiation and Tests for Natural
Selection
To test for differentiating natural selection, we compared
the frequencies of the putative susceptibility variants be-
tween populations in which malaria is endemic and non-
endemic (tables 3 and A2). We observed the most-signif-
icant frequency differentiation at the two SNPs that also
showed the strongest associations (table 3). The sickle-cell
allele HbAS T is present at appreciable frequency in the
Luo (13%) and Yoruba (11%) but is absent in the malaria-
nonendemic Masai and Kikuyu. The CD36 G allele is pre-
sent at 22% in the Yoruba and at 6% in the Luo but occurs
at only ∼1% frequency in the populations in which ma-
laria is nonendemic.
To test whether these allele-frequency differences are
greater than what could be explained in the absence of
selection, we compared them with a panel of 1,454 ran-
dom SNPs30 for which we obtained genotypes in 45 Luo,
47 Masai, 37 Kikuyu, and 59 Yoruba. (We ﬁrst assessed
whether there was evidence of population substructure in
the Luo,31 which could, in principle, confound our case-
control tests of association. No structure was detected, in-
dicating that population stratiﬁcation is not likely to cause
false-positive or false-negative results in the association
analysis.) We also used the data to assess the genetic re-
lationships among the populations; understanding this is
crucial to the tests for differentiating selection.
The genetic differentiation among populations ranges
from between Masai and Kikuyu (lowest dif-F p 0.0012ST
ferentiation) to between Yoruba and MasaiF p 0.021ST
(highest differentiation).We found that the Luo andMasai
do not cluster genetically, despite the fact that they both
speak Nilotic languages, whereas the Masai and Kikuyu
are closely related (despite the fact that the Kikuyu speak
a Bantu language) (ﬁg. 1). These results show that the
linguistic patterns in Kenya do not correlate with the ge-
netic patterns, which is at odds with what has been sug-
gested elsewhere.32 Sampling of more populations should
elucidate the relationships between genetic and linguistic
groups in East Africa.33
To formally test for differentiating selection, we com-
puted a x2 statistic for frequency differentiation at each
tested SNP, assuming it was drawn from the empirical
distribution deﬁned by 1,454 random SNPs (see the “Ma-
terial and Methods” section and table 3). Allele-frequency
differentiation between malaria-endemic and -nonendem-
ic populations is signiﬁcant at HbAS T ( forPp .00036
the most extreme Luo-Kikuyu comparison) and CD36 G
( for Yoruba-Kikuyu), with the results signiﬁ-Pp .00096
cant even after use of a Bonferroni correction for testing
40 comparisons of malaria-endemic and -nonendemic
populations at 10 SNPs (this essentially involves multi-
plying the nominal P values by a factor of 40). By contrast,
the eight SNPs that do not give positive case-control as-
sociation show no evidence of differentiating selection
( for each SNP and pair of populations after correc-P 1 .25
tion for multiple hypotheses tested; for the sumPp .39
of 32 x2 statistics at these eight SNPs).We further evaluated
the robustness of our selection test by computing x2 sta-
tistics for each of the 1,454 random SNPs for each of the
four pairs of populations. If the test is robust, we would
expect to achieve a x2 value 13.84, with probability 0.05.
Restricting the analysis to SNPs in which the average allele
frequency across the two populations tested was at least
5%, we observed a x2 value 13.84 in 255 (5%) of 5,090 of
tests performed. Similarly, only 4 of 5,090 tests produced
a P value !.001, and the lowest P value was not statistically
signiﬁcant after correction for 5,090 hypotheses tested
( ). These results show that our test for differenti-P 1 .16
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Table 4. Formal Combination of Case-Control Association Analysis and Tests of Natural
Selection
Allele
Reference
SNP
Pa
Luo vs.
Masai
Luo vs.
Kikuyu
Yoruba vs.
Masai
Yoruba vs.
Kikuyu
HbAS T rs334 .000056 .000018 .00048 .00029
CD36 G rs3211938 NA NA .0023 .00043
ICAM T rs5491 .19 .23 .32 .36
NOS2A 1659 A rs8078340 .033 .038 .032 .038
TNF 238 A rs361525 .12 .30 .028 .038
CD32 A rs1801274 .96 .65 .96 .81
IFNARI L168V C rs2257167 .34 .68 .52 .73
TNF 308 A rs1800629 .63 .69 .76 .75
IFNARI 17470 C rs1012335 .91 .79 .56 .38
TLR4 G rs4986790 .42 .41 .38 .42
a P values from combining case-control association studies with the test for differentiating selection
between malaria-endemic (Luo and Yoruba) and -nonendemic (Masai and Kikuyu) populations. Values in
bold are signiﬁcant. NA p not available.
ating natural selection is not prone to false-positive results
in a large selection of randomly chosen SNPs.
We note that both HbAS T and CD36 G have been iden-
tiﬁed elsewhere as targets of recent positive natural se-
lection.22,34–36 However, the long-range haplotype test used
to detect selection at these alleles detects evidence of se-
lection from any cause and thus is not speciﬁc to a par-
ticular type of selection (e.g., for malaria resistance). The
tests of allele-frequency differentiationwe present here are
much more speciﬁc to malaria. By comparing malaria-en-
demic and -nonendemic populations, we increase the
probability that the loci detected as being affected by se-
lection are speciﬁcally associated with malaria resistance.
Of all the SNPs we tested for population differentiation—
1,454 random SNPs and 10 candidates for malaria suscep-
tibility—2 of those that achieve a nominal P value !.001
for at least one pair of populations were among the can-
didate malaria-resistance SNPs.
Combined Analysis of Case-Control Association
and Selection
Finally, we formally combined the evidence of associa-
tion with the evidence from the selection test (see the
“Material and Methods” section). The combined test eval-
uates whether the observed data are consistent with the
model of no case-control association and no selection.
Whereas the evidence of association at HbAS T and CD36
G is only moderate by the association analysis alone (see
P values in table A1), signiﬁcance is greatly increased when
the association and selection evidence is combined: Pp
–.00029 forHbAS T and –.017 forCD36.000018 Pp .00043
G, depending on which populations are compared (table
4). These results remain statistically signiﬁcant after cor-
rection for 40 hypotheses tested ( for HbAS TPp .00072
and for CD36 G).Pp .017
Discussion
We performed a case-control association study of malaria
resistance in the Luo, an East African population, analyz-
ing 10 previously implicated variants. We replicated as-
sociations atHbAS (OR 0.57 [95%CI 0.41–0.79]) andCD36
(OR 1.50 [95%CI 1.05–2.18]). Our OR forCD36 is in agree-
ment with the results published elsewhere.12 Similarly, the
OR for HbAS is in agreement with the previously reported
longitudinal study in the same population (OR 0.45 [95%
CI 0.24–0.84]; ).10 ForHbAS, the protective effectPp .0001
that we observed is smaller than in some previous reports,
which is potentially due to the fact that the cases we stud-
ied were young (average age 2.6 years) and thus lacked an
immune basis for HbAS protection. (Williams and col-
leagues showed that HbAS has a more protective effect for
older individuals.9,10,26) A possible reason why we did not
replicate all the previous associations is that, in our study,
the phenotype was parasitemia, whereas previous studies
sometimes focused on cerebral malaria (table 2). We also
show in table 2 that the CIs for the ORs are broad; thus,
many of the variants we tested are consistent with an
effect on malaria susceptibility, even if we could not reject
the hypothesis of no association.
A particularly striking observation is that, at CD36,
where we observe signiﬁcant case-control association and
highly signiﬁcant allele-frequency differentiation, the
variant increasing susceptibility actually has higher fre-
quency in malaria-endemic populations. A possible his-
torical explanation is that the selection pressures on this
variant may have changed over time because of host-par-
asite genetic interactions. For example, the variant may
have historically reduced susceptibility to malaria, and
then, as the parasite evolved to adapt to the human im-
mune system, the allelic association might have reversed.
This hypothesis would be consistent with the known tem-
poral and geographical heterogeneity in CD36 binding
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Figure 1. Principal-components analysis of samples from four different populations genotyped for 1,454 SNPs. The ﬁrst eigenvector
clusters the Yoruba, Luo, Kikuyu, and Masai. This is contrary to the expectation based on linguistics (the Luo and Masai both speak
Nilotic languages) or geography. The FST values estimated between pairs of populations are as follows: Yoruba-Luo, 0.008; Yoruba-Masai,
0.021; Yoruba-Kikuyu, 0.015; Luo-Kikuyu, 0.008; Luo-Masai, 0.011; and Kikuyu-Masai, 0.0012. The top eigenvector is highly statistically
signiﬁcant by principal-components analysis31 ( ). The second eigenvector is not signiﬁcant ( ).12P K 10 Pp .09
and pathogenicity.12 For example, genetic variation at the
PfEMP1 gene in the malaria parasite has been shown else-
where to be associated with the pathogenicity,37,38 andpar-
asite PfEMP1 and human CD36 are known to interact.39–
41 In future studies, it will be interesting to explorewhether
human variants at CD36 have different interactions with
genetically different malaria parasite strains.42
These results ﬁnally provide empirical validation for a
long-standing idea.21 The idea is that, to increase power
in case-control studies, one can combine the evidence of
association with that from tests of natural selection. Pre-
vious studies have prioritized SNPs by natural selection on
the basis of a combination of the alleles being frequent
and being surrounded by a long-range haplotype3,22,43; the
present study adds to this in several ways. First, we provide
a formal x2 test of statistical signiﬁcance, which can be
combined with a case-control statistic to provide evidence
that a SNP is a statistical outlier and, thus, a strong can-
didate for being associated with malaria. Second, our se-
lection evidence is more speciﬁc to our phenotype of in-
terest, since we are comparing frequency variants in pop-
ulations differentiated by whether malaria has been his-
torically endemic or nonendemic. Tishkoff et al.33 recently
applied a similar strategy to the phenotype of lactase per-
sistence. They compared pastoral and nonpastoral popu-
lations in East Africa that have been differently exposed
to diets including cow’s milk. This analysis demonstrated
high allele-frequency differences at variants near the lac-
tase gene LCT and simultaneously showed that these
highly differentiated variants also conferred the pheno-
type of lactase persistence.
We conclude that, in future whole-genome association
scans, evidence from case-control comparisons can be
combined with allele-frequency differentiation between
differently exposed populations—and, potentially, other
sources of evidence about recent selection22,43—to provide
increased sensitivity and power in tests to detect disease-
related genetic variants. It has been suggested that the
identiﬁcation of targets of selection may soon become a
mainstream approach to ﬁnding genetic variants affecting
human disease; our results provide empirical validation
for this idea.44 In our study, P values for HbAS and CD36
were enhanced by several orders of magnitude with the
use of !60 samples from each population analyzed, sug-
gesting that this strategy may be cost effective relative to
the number of additional samples needed to obtain a sim-
ilar increase in power within the conventional case-con-
trol paradigm.
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Appendix A
Table A1. Statistical Tests for Association
Genotype/Allele,
Reference SNP,
and Sex
Frequency
in Luo
Controls
(%)
No. of
Cases/
Controls OR (95% CI)
P in Two-Tailed (One-Tailed)
Tests of Previously Associated
P in Tests
Based on 3#2
Genotype TableGenotype Allele
HbAS AT:
rs334:
All 25 447/454 .57 (.41–.79) .0008 (.0004) .006 (.003) .0031
Female 25 232/175 .55 (.33–.90) .02 (.01)
Male 25 215/279 .59 (.38–.93) .02 (.01)
CD36 GT:
rs3211938:
All 12 456/457 1.50 (1.03–2.18) .03 (.015) .06 (.03) .061
Female 12 232/174 1.40 (.85–2.33) 1.19 (.60)
Male 13 224/283 1.57 (.90–2.74) .11 (0.06)
ICAM TT:
rs5491:
All 7 460/455 .71 (.42–1.21) .20 (.10) .89 (.45) .22
Female 8 235/176 .43 (.18–1.00) .04 (.02)
Male 7 225/279 1.05 (.53–2.09) .90 (.45)
NOS2A 1659 AA:
rs8078340:
All 6 450/455 .42 (.21–.83) .01 (.99) .69 (.5) .015
Female 6 229/179 .55 (.22–1.40) .21 (.11)
Male 6 221/276 .28 (.09–.85) .02 (.01)
TNF 238 A:
rs361525:
All 9 459/457 1.00 (.73–1.39) .28 (.14) .97 (.49) .47
Female 8 233/173 1.33 (.82–2.17) .24 (.12)
Male 9 226/284 .74 (.47–1.16) .20 (.10)
CD32 AA:
rs1801274:
All 25 455/447 .95 (.71–1.29) .76 (.38) .81 (.45) .95
Female 24 229/176 1.06 (.67–1.67) .37 (.19)
Male 25 226/271 .45 (.30–.70) .66 (.33)
IFNARI LI168V CC:
rs2257167:
All 3 455/457 1.18 (.54–2.07) .48 (.76) .93 (.47) .86
Female 2 231/180 1.37 (.45–4.17) .37 (.19)
Male 3 224/277 .37 (.11–1.24) .66 (.33)
TNF 308 A:
rs1800629:
All 9 450/433 1.13 (.82–1.56) .21 (.11) .42 (.21) .25
Female 6 234/166 1.33 (.75–2.37) .33 (.17)
Male 11 216/267 1.17 (.78–1.74) .45 (.23)
IFNARI 17470 CC:
rs1012335:
All 3 455/452 .85 (.53–1.36) .68 (.34) .70 (.35) .78
Female 2 234/180 1.73 (.52–5.70) .34 (.17)
Male 3 221/272 .46 (.15–1.43) .66 (.33)
TLR4 AG:
rs4986790:
All 10 407/299 1.36 (.86–2.17) .20 (.10) .067 (.02) .20
Female 9 201/123 1.48 (.70–3.16) .67 (.34)
Male 11 206/176 1.33 (.74–2.40) .17 (.09)
NOTE.—This table is an expansion of table 2. Values in bold are signiﬁcant.
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Table A2. Allele Counts in Cases and Controls for the 10 Polymorphisms
Allele
Reference
SNP
Luo
Controls Luo Cases Masai Kikuyu Yoruba
Ref Var Ref Var Ref Var Ref Var Ref Var
HbAS T rs334 789 119 819 75 194 0 200 0 91 11
CD36 G rs3211938 856 58 883 79 184 2 202 0 78 22
ICAM T rs5491 683 227 688 232 156 30 169 37 76 24
NOS2A 1659 A rs8078340 714 196 713 187 141 47 162 42 79 19
TNF 238 G rs361525 833 81 837 81 152 40 169 33 99 1
CD32 A rs1801274 454 446 453 455 95 95 92 118 49 49
IFNARI LI168V C rs2257167 764 150 762 148 144 48 168 40 98 16
TNF 308 A rs1800629 791 75 813 87 176 12 189 15 90 6
IFNARI 17470 C rs1012335 616 288 622 280 128 62 131 71 84 24
TLR4 G rs4986790 571 31 755 59 165 13 161 9 109 5
NOTE.—Ref p reference allele; Var p variant allele.
Web Resource
The URL for data presented herein is as follows:
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi
.nlm.nih.gov/Omim/ (for malaria infection)
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